All AbMole products are for research use only, cannot be used for human consumption.
Gemzil is a PPAR-α activator, which is a lipid-lowering agent. Gemfibrozil is also a nonselective inhibitor of P450, with Ki values of 5.8, 24,69 and 82 μM for CYP2C9, 2C19, 2C8 and 1A2, respectively.
| Molecular Weight | 250.33 |
| Formula | C15H22O3 |
| CAS Number | 25812-30-0 |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[1] Aleksi Tornio, et al. Role of gemfibrozil as an inhibitor of CYP2C8 and membrane transporters
[2] Barbara S Wiggins, et al. Gemfibrozil in Combination with Statins-Is It Really Contraindicated?
[3] No authors listed. IARC Monogr Eval Carcinog Risks Hum. Gemfibrozil
| Related PPAR Products |
|---|
| WY 14643 (Pirinixic Acid)
WY 14643 (Pirinixic Acid) is a potent and selective, peroxisome proliferator-activated receptor-α (PPARα) agonist. |
| GSK 3787
GSK3787 is an orally available selective peroxisome proliferator-activated receptor δ (PPARδ) antagonist (pIC50 = 6.6). |
| Ciprofibrate
Ciprofibrate is a peroxisome proliferator-activated receptor α (PPARα) agonist. |
| ZLN005
ZLN005 is a novel and potent small molecule PGC-1α transcriptional activator. |
| Bezafibrate
Bezafibrate is the first clinically tested dual and pan-PPAR co-agonism. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
